"10.1371_journal.pone.0107116","plos one","2014-09-25T00:00:00Z","Claire Wu; Jessica Yuen; Heidi N Boyda; Ric M Procyshyn; Cathy K Wang; Yahya I Asiri; Catherine C Y Pang; William G Honer; Alasdair M Barr","Department of Pharmacology, University of British Columbia, Vancouver, British Columbia, Canada; Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada; British Columbia Mental Health and Addictions Research Institute, Vancouver, British Columbia, Canada","Conceived and designed the experiments: CW JY HNB RMP CCYP WGH AMB. Performed the experiments: CW JY HNB CKW YIA. Analyzed the data: RMP CCYP WGH AMB. Contributed to the writing of the manuscript: CW HNB RMP CCYP AMB.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: Dr. Procyshyn is a paid consultant for and is on the speakers bureau for AstraZeneca, Bristol-Myers Squibb, Janssen, Otsuka, Pfizer, and Sunovion. He also has funding from the Canadian Institute of Health Research. Dr. Honer has received consulting fees or sat on paid advisory boards for: MDH Consulting, In Silico (no honorarium), Novartis, Roche, Otsuka, and Lundbeck; received honoraria from Rush University, the Korean Society for Schizophrenia Research, the Centre for Addiction and mental Health (Toronto), the BC Schizophrenia Society, the Fraser, Vancouver Coastal and the Providence Health Authorities, and the Canadian Agency for Drugs and Technology in Health; provided expert testimony for Fasken Martineau DuMoulin, Cave and Company, and Hartshorne & Mehl; and received grants from the Canadian Institute of Health Research. Dr. Barr has received grants from Bristol-Myers Squibb and the Canadian Institute of Health Research. All other authors declare no potential competing interests. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","09","Claire Wu","CW",9,TRUE,7,5,4,NA,TRUE,FALSE,FALSE,0,NA,FALSE
